Skip to Content

Join the 'Lupus Erythematosus' group to help and get support from people like you.

Lupus Erythematosus News

Related terms: Discoid Lupus Erythematosus, DLE

Gut Microbes May Help Drive Lupus, Study Finds

Posted 20 Feb 2019 by Drugs.com

WEDNESDAY, Feb. 20, 2019 – An imbalance in the gut "microbiome" of people with lupus may be driving the chronic autoimmune disease as well as its flare-ups, new research suggests. The microbiome is the trillions of helpful bacteria that coexist in the human digestive tract and elsewhere in the body. Comparing gut bacteria from lupus patients with bacteria from their healthy peers, scientists...

Pregnancy Complications Down for Women With Lupus

Posted 22 Oct 2018 by Drugs.com

MONDAY, Oct. 22, 2018 – Deaths and complications among pregnant women with lupus have declined in the United States over the past two decades, a new study finds. Lupus, also called systemic lupus erythematosus (SLE), is a chronic autoimmune disease that causes inflammation in many parts of the body, including the kidneys, skin and joints, as well as the tissue lining the lungs, heart and brain....

Scans Help Spot Heart Trouble Early in People With Lupus

Posted 2 Aug 2018 by Drugs.com

THURSDAY, Aug. 2, 2018 – Heart disease is a leading cause of death in patients with the autoimmune illness lupus. Now, research suggests high-tech scans can spot cardiac issues early. The scans can detect heart abnormalities even before patients have any symptoms, Chinese researchers say. "Our findings may affect current lupus diagnostics and treatment – meaning more patients with silent...

Could Fish Oil, Vitamin D Help Ease Lupus?

Posted 10 Nov 2017 by Drugs.com

THURSDAY, Nov. 9, 2017 – People with lupus may fare better if they have enough vitamin D and omega-3 fats in their diet, preliminary research suggests. In separate studies, researchers linked the two nutrients – or lack thereof – to higher risks of certain lupus symptoms and complications. In one, lupus patients with low blood levels of vitamin D faced a higher risk of kidney damage than those...

Exercise May Stem Kidney Damage in Lupus Patients

Posted 19 Sep 2017 by Drugs.com

TUESDAY, Sept. 19, 2017 – Regular exercise may slow kidney damage in people with lupus while stress may prompt the opposite effect, new research suggests. The autoimmune disease causes the body to attack and damage vital organs such as the kidneys. Singer Selena Gomez put lupus in the spotlight last week when she received a kidney transplant because the disease had ravaged her own kidneys. But...

Selena Gomez's Kidney Transplant Puts Lupus Center Stage

Posted 15 Sep 2017 by Drugs.com

FRIDAY, Sept. 15, 2017 – When pop star Selena Gomez revealed Thursday that she had a kidney transplant, she put the autoimmune disease lupus in the spotlight. Lupus turns the body's immune system against itself and attacks vital organs, including the kidneys, which is why it's so devastating. But little is known about what causes the disease, and no real cure exists. Treatments can only keep it...

Lupus Hits Certain Groups Harder

Posted 11 Sep 2017 by Drugs.com

MONDAY, Sept. 11, 2017 – There are significant ethnic and racial disparities in the rates of lupus in the United States, two new studies report. Researchers reviewed registries of people living in San Francisco and New York City with the autoimmune disease. They found that the prevalence of lupus was higher in San Francisco than in Manhattan – 85 people versus 62 people per every 100,000. Women...

GSK Receives FDA Approval for a New Self-Injectable Formulation of Benlysta (belimumab) for Systemic Lupus Erythematosus

Posted 24 Jul 2017 by Drugs.com

London, UK 21 July 2017 – GSK announced today that the US Food and Drug Administration (FDA) has approved a new subcutaneous formulation of Benlysta (belimumab) for the treatment of adult patients with active, autoantibody‑positive SLE who are receiving standard therapy. Systemic Lupus Erythematosus (SLE) is the most common form of lupus, a chronic, incurable autoimmune disease producing a...

Poverty Could Make Lupus Even Worse

Posted 19 May 2017 by Drugs.com

FRIDAY, May 19, 2017 – Poverty and race are tied to the health of lupus patients in the United States, according to two new studies. One study of 783 patients linked poverty to an increased risk of organ damage from the autoimmune disease. It was published in the journal Arthritis & Rheumatology. "Persistent poverty and being poor in an area of concentrated poverty seem to worsen the amount of...

Delays in Lupus Care Seen Among Minorities, Less Educated

Posted 18 Nov 2016 by Drugs.com

FRIDAY, Nov. 18, 2016 – Delays in lupus treatment are more common among Americans who are black, Asian or are less educated, a new study finds. Lupus is a chronic autoimmune disease in which inflammation affects the skin, joints, kidneys and other organs. The disease occurs far more often in women than men, and also may have a higher prevalence among some ethnic groups, the researchers said. It...

Researchers Pinpoint More Genes Linked to Vitiligo

Posted 12 Oct 2016 by Drugs.com

WEDNESDAY, Oct. 12, 2016 – Researchers say they've identified more genes linked to the autoimmune disease vitiligo, which causes patches of white skin and hair. An international team of scientists pinpointed 23 new locations on the genome associated with susceptibility to vitiligo. That doubles the number of known genes connected with vitiligo, the researchers said. Vitiligo may be related to...

Lupus a Tough Disease to Spot, Treat

Posted 30 May 2016 by Drugs.com

MONDAY, May 30, 2016 – Lupus is difficult to diagnose and treat, but scientists are working to learn more about its genetic causes and to develop better treatments. The autoimmune disease affects between 300,000 and 1.5 million people in the United States, and as many as 24,000 are diagnosed with lupus each year, according to the U.S. Food and Drug Administration. "With treatment, the disease...

FDA Approves Benlysta to Treat Lupus

Posted 10 Mar 2011 by Drugs.com

March 9, 2011 – The U.S. Food and Drug Administration today approved Benlysta (belimumab) to treat patients with active, autoantibody-positive lupus (systemic lupus erythematosus) who are receiving standard therapy, including corticosteroids, antimalarials, immunosuppressives, and nonsteroidal anti-inflammatory drugs. Benlysta is delivered directly into a vein (intravenous infusion) and is the...

Ask a Question

Further Information

Related Condition Support Groups

Systemic Lupus Erythematosus